Latest Articles

Article Type

You have access
Phenobarbital in Nuclear Receptor Activation: An Update
Shuaiqian Men and Hongbing Wang

Drug Metabolism and Disposition February 2023, 51 (2) 210-218; DOI: https://doi.org/10.1124/dmd.122.000859
You have access
Microbial Metabolites as Ligands to Xenobiotic Receptors: Chemical Mimicry as Potential Drugs of the Future
Zdeněk Dvořák, Hao Li and Sridhar Mani

Drug Metabolism and Disposition February 2023, 51 (2) 219-227; DOI: https://doi.org/10.1124/dmd.122.000860
You have access
Pharmacokinetic Interactions of a Licorice Dietary Supplement with Cytochrome P450 Enzymes in Female Participants
Jialin Liu, Suzanne Banuvar, Marlos Viana, Elena Barengolts, Shao-Nong Chen, Guido F. Pauli and Richard B. van Breemen

Drug Metabolism and Disposition February 2023, 51 (2) 199-204; DOI: https://doi.org/10.1124/dmd.122.001050
You have access
The Function of Xenobiotic Receptors in Metabolic Diseases
Jinhang Zhang, Qingyi Jia, Yanping Li and Jinhan He

Drug Metabolism and Disposition February 2023, 51 (2) 237-248; DOI: https://doi.org/10.1124/dmd.122.000862
You have access
Special Section on Xenobiotic Receptors–Editorial
Xiao-bo Zhong and Yurong Lai

Drug Metabolism and Disposition February 2023, 51 (2) 205-206; DOI: https://doi.org/10.1124/dmd.122.001207
You have access
Regulation of Nuclear Receptors PXR and CAR by Small Molecules and Signal Crosstalk: Roles in Drug Metabolism and Beyond
Shyaron Poudel, Andrew D. Huber and Taosheng Chen

Drug Metabolism and Disposition February 2023, 51 (2) 228-236; DOI: https://doi.org/10.1124/dmd.122.000858
You have access
Renal Transporter Alterations in Patients with Chronic Liver Diseases: Nonalcoholic Steatohepatitis, Alcohol-Associated, Viral Hepatitis, and Alcohol-Viral Combination
Kayla L. Frost, Joseph L. Jilek, Shripad Sinari, Robert R. Klein, Dean Billheimer, Stephen H. Wright and Nathan J. Cherrington

Drug Metabolism and Disposition February 2023, 51 (2) 155-164; DOI: https://doi.org/10.1124/dmd.122.001038
You have access
Bioavailability and Pharmacokinetics of Endoxifen in Female Rats and Dogs: Evidence to Support the Use of Endoxifen to Overcome the Limitations of CYP2D6-Mediated Tamoxifen Metabolism
Emily J. Koubek, Sarah A. Buhrow, Stephanie L. Safgren, Lee Jia, Matthew P. Goetz, Matthew M. Ames and Joel M. Reid

Drug Metabolism and Disposition February 2023, 51 (2) 183-192; DOI: https://doi.org/10.1124/dmd.122.000929
You have access
Clinical Pharmacology of RNA Interference–Based Therapeutics: A Summary Based on Food and Drug Administration–Approved Small Interfering RNAs
Xing Jing, Vikram Arya, Kellie Schoolar Reynolds and Hobart Rogers

Drug Metabolism and Disposition February 2023, 51 (2) 193-198; DOI: https://doi.org/10.1124/dmd.122.001107
You have access
Metabolic Disposition of Triazolam and Clobazam in Humanized CYP3A Mice with a Double-Knockout Background of Mouse Cyp2c and Cyp3a Genes
Kaoru Kobayashi, Genki Minegishi, Nina Kuriyama, Atsushi Miyajima, Satoshi Abe, Kanako Kazuki and Yasuhiro Kazuki

Drug Metabolism and Disposition February 2023, 51 (2) 174-182; DOI: https://doi.org/10.1124/dmd.122.001087

Main menu

User menu

Search

Latest Articles

Pages

Navigate

More Information

ASPET's Other Journals